LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
Podcasts & Webcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
BioCentury-BayHelix China Healthcare Summit
East-West Healthcare Reception
BioCentury-BayHelix East-West Summit
Bio€quity Europe
BioCentury Grand Rounds Inquiry
The BioCentury Show
Webinars - Upcoming & On-Demand
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
China Everbright Ltd.
BioCentury
|
Oct 26, 2018
Financial News
First close for China Everbright’s new healthcare fund
Read More
BioCentury
|
Oct 23, 2018
Financial News
First close for China Everbright’s new healthcare fund
Read More
BioCentury
|
Jan 5, 2018
Company News
Ambrx gets Chinese rights to Tracon's carotuximab
Read More
BioCentury
|
Jan 6, 2017
Company News
Ambrx, MabSpace deal
Read More
BioCentury
|
Aug 8, 2016
Financial News
Ambrx completes venture financing
Read More
BioCentury
|
Aug 4, 2016
Financial News
Ambrx raises $45M
Read More
BioCentury
|
Mar 10, 2016
Targets & Mechanisms
Brown fat heats up
Casting a wide net for brown and beige fat targets in metabolic diseases
Read More
BioCentury
|
Oct 19, 2015
Regulation
Unleashing China's innovators
How China FDA reforms may unleash development of innovative drugs
Read More
BioCentury
|
May 25, 2015
Company News
Ambrx, China Everbright, Hopu Investment Management, Shanghai Fosun Pharmaceutical, WuXi PharmaTech deal
Read More
BioCentury
|
May 23, 2015
Company News
Chinese consortium to acquire Ambrx
Read More
Items per page:
10
1 - 10 of 10